Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 7, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2020. Go to the latest filing (Q3 2026)

23.1B USDQ2 2020
Total value of stock positions
23.1B USD
Positions
72
Share of the ten largest
44.3%

The ten largest positions Q2 2020

  1. Amazon 7.3%▼ −30.4%
  2. Adaptive Biotechnologies Cor 7.0%unchanged
  3. Comcast 4.8%▲ +59.3%
  4. Centene Corporation 4.4%▼ −0.8%
  5. American Express 4.3%▲ +170.7%
  6. Fidelity National Information Services 3.9%▲ +76.7%
  7. Bridgebio Pharma Inc 3.8%unchanged
  8. Microsoft 3.3%▼ −24.3%
  9. Boston Scientific 2.8%▼ −42.0%
  10. Thermo Fisher Scientific 2.7%new
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q2 2020

Positions Q2 2020 per 13F filing, 72 of 72
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 7.3% 612,886 1.7B USD −30.4% reduced Q2 2015 21 quarters
NFLX Netflix 0.7% 356,549 162.2M USD −86.6% reduced Q3 2015 20 quarters
Editas Medicine Inc < 0.1% 413,000 12.2M USD −19.4% reduced Q1 2016 18 quarters
MSFT Microsoft 3.3% 3,710,674 755.2M USD −24.3% reduced Q2 2016 17 quarters
V Visa Inc. 0.1% 164,889 31.9M USD −61.7% reduced Q3 2016 16 quarters
Liberty Media Corp Del 0.3% 1,923,501 61.0M USD unchanged Q1 2017 14 quarters
Catalent Inc 0.5% 1,493,703 109.5M USD −22.9% reduced Q1 2018 10 quarters
CNC Centene Corporation 4.4% 16,106,578 1.0B USD −0.8% reduced Q2 2018 9 quarters
BSX Boston Scientific 2.8% 18,457,273 648.0M USD −42.0% reduced Q3 2018 8 quarters
AON Aon plc 2.5% 2,956,029 569.3M USD +29.1% increased Q3 2018 8 quarters
Exact Sciences Corp 0.8% 2,182,534 189.8M USD −10.1% reduced Q3 2018 8 quarters
Blueprint Medicines Corp 0.5% 1,629,716 127.1M USD +1.8% increased Q3 2018 8 quarters
JD JD.com (ADR) 2.1% 8,266,459 497.5M USD −56.2% reduced Q1 2019 6 quarters
MELI MercadoLibre 0.3% 69,344 68.4M USD −82.2% reduced Q1 2019 6 quarters
Adaptive Biotechnologies Cor 7.0% 33,493,708 1.6B USD unchanged Q2 2019 5 quarters
Bridgebio Pharma Inc 3.8% 26,620,991 868.1M USD unchanged Q2 2019 5 quarters
UBER Uber 2.2% 16,470,839 511.9M USD −37.2% reduced Q2 2019 5 quarters
CRM Salesforce 1.7% 2,145,463 401.9M USD −38.8% reduced Q2 2019 5 quarters
AIZ Assurant 1.3% 2,826,277 291.9M USD +31.6% increased Q2 2019 5 quarters
LOW Lowe's 1.0% 1,710,360 231.1M USD −68.7% reduced Q2 2019 5 quarters
Avantor Inc 0.4% 5,475,379 93.1M USD −45.5% reduced Q2 2019 5 quarters
FTV Fortive 2.6% 8,760,046 592.7M USD −7.0% reduced Q3 2019 4 quarters
Guardant Health Inc 1.1% 3,068,173 248.9M USD −19.2% reduced Q3 2019 4 quarters
Molina Healthcare Inc 0.8% 1,013,668 180.4M USD −25.8% reduced Q3 2019 4 quarters
Genmab A/S < 0.1% 575,086 19.5M USD −31.6% reduced Q3 2019 4 quarters
Atyr Pharma Inc < 0.1% 587,444 2.6M USD unchanged Q3 2019 4 quarters
CMCSA Comcast 4.8% 28,523,676 1.1B USD +59.3% increased Q4 2019 3 quarters
FIS Fidelity National Information Services 3.9% 6,714,021 900.3M USD +76.7% increased Q4 2019 3 quarters
CI Cigna 2.4% 2,949,644 553.5M USD +15.8% increased Q4 2019 3 quarters
BKNG Booking Holdings 1.4% 202,747 322.8M USD +8.5% increased Q4 2019 3 quarters
Anaplan Inc 1.1% 5,746,829 260.4M USD +4,823.5% increased Q4 2019 3 quarters
SE Sea Limited (ADR) 0.8% 1,727,380 185.2M USD +30.5% increased Q4 2019 3 quarters
Bristol-Myers Squibb Co 0.3% 18,968,019 67.9M USD −3.4% reduced Q4 2019 3 quarters
Viela Bio Inc 0.2% 1,049,000 45.4M USD −16.1% reduced Q4 2019 3 quarters
AXP American Express 4.3% 10,497,498 999.4M USD +170.7% increased Q1 2020 2 quarters
JPM JPMorgan Chase 2.6% 6,411,486 603.1M USD +56.9% increased Q1 2020 2 quarters
LVS Las Vegas Sands 2.2% 11,125,343 506.6M USD +259.5% increased Q1 2020 2 quarters
TMUS T-Mobile US 1.7% 3,799,550 395.7M USD +203.0% increased Q1 2020 2 quarters
IR Ingersoll Rand 1.2% 10,196,427 286.7M USD −15.1% reduced Q1 2020 2 quarters
WDAY Workday, Inc. 1.2% 1,490,882 279.3M USD −39.4% reduced Q1 2020 2 quarters
CB Chubb Limited 1.2% 2,202,033 278.8M USD +139.7% increased Q1 2020 2 quarters
MU Micron Technology 0.8% 3,392,745 174.8M USD −49.5% reduced Q1 2020 2 quarters
Encompass Health Corp 0.7% 2,677,612 165.8M USD +85.2% increased Q1 2020 2 quarters
COO Cooper Companies (The) 0.4% 345,523 98.0M USD −20.9% reduced Q1 2020 2 quarters
Horizon Therapeutics Pub Ltd 0.4% 1,471,419 81.8M USD −26.1% reduced Q1 2020 2 quarters
CME CME Group 0.3% 482,679 78.5M USD −71.6% reduced Q1 2020 2 quarters
Change Healthcare Inc 0.2% 4,326,999 48.5M USD −66.1% reduced Q1 2020 2 quarters
Varian Med Sys Inc 0.2% 365,827 44.8M USD −57.8% reduced Q1 2020 2 quarters
TMO Thermo Fisher Scientific 2.7% 1,734,144 628.4M USD new Q2 2020 1 quarter
HLT Hilton Worldwide 2.3% 7,272,455 534.2M USD new Q2 2020 1 quarter
Api Group Corp 1.8% 33,333,333 405.0M USD new Q2 2020 1 quarter
Nuance Communications Inc 1.4% 12,799,556 323.9M USD new Q2 2020 1 quarter
MCO Moody's Corporation 1.2% 977,348 268.5M USD new Q2 2020 1 quarter
PH Parker Hannifin 1.1% 1,442,793 264.4M USD new Q2 2020 1 quarter
ADI Analog Devices 1.0% 1,959,943 240.4M USD new Q2 2020 1 quarter
SHW Sherwin-Williams 1.0% 397,835 229.9M USD new Q2 2020 1 quarter
DRI Darden Restaurants 1.0% 2,991,636 226.7M USD new Q2 2020 1 quarter
Zentalis Pharmaceuticals Inc 0.9% 4,443,284 213.4M USD new Q2 2020 1 quarter
ALL Allstate 0.7% 1,769,570 171.6M USD new Q2 2020 1 quarter
LIN Linde plc 0.7% 803,694 170.5M USD new Q2 2020 1 quarter
DHR Danaher Corporation 0.7% 903,929 159.8M USD new Q2 2020 1 quarter
BABA Alibaba Group (ADR) 0.6% 695,536 150.0M USD new Q2 2020 1 quarter
ALGN Align Technology 0.6% 539,343 148.0M USD new Q2 2020 1 quarter
Royalty Pharma PLC 0.5% 2,514,985 122.1M USD new Q2 2020 1 quarter
Envista Holdings Corporation 0.4% 4,524,346 95.4M USD new Q2 2020 1 quarter
EG Everest Group 0.4% 418,223 86.2M USD new Q2 2020 1 quarter
TJX TJX Companies 0.3% 1,519,986 76.9M USD new Q2 2020 1 quarter
Pvh Corporation 0.3% 1,522,984 73.2M USD new Q2 2020 1 quarter
Momenta Pharmaceuticals Inc 0.1% 946,220 31.5M USD new Q2 2020 1 quarter
Agora Inc < 0.1% 400,000 17.7M USD new Q2 2020 1 quarter
Uniqure NV < 0.1% 62,396 2.8M USD new Q2 2020 1 quarter
T-Mobile US Inc < 0.1% 1,799,550 302.0K USD new Q2 2020 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 18.5%
  • Consumer Discretionary 15.5%
  • Health Care 14.1%
  • Technology 8.0%
  • Communication Services 7.2%
  • Industrials 7.2%
  • Materials 1.7%
  • not in our coverage 27.8%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close